Y-mabs announces 2019 financial results and recent corporate developments

Y-mabs announces 2019 financial results and recent corporate developments.y-mabs therapeutics, inc - company had approximately $207.1 million in cash and cash equivalents as of december 31, 2019.

YMAB Ratings Summary

YMAB Quant Ranking